Tata Capital to invest in Mitra biotech Illustrative image – not actual.

Tata Capital Innovations Fund, along with existing investors, India Innovation Fund and Accel Partners, is planning to invest in Bangalore-based cancer care provider, Mitra Biotech.

 

The company will invest Rs 40 crore in Mitra Biotech, founded by a team of medical researchers from the Massachusetts Institute of Technology and Harvard Medical School. The fund will be used to scale operations, expand globally and strengthen the business development and research teams, according to Sundaram.

 

In 2010, Mitra Biotech had raised Rs 30 crore from Accel, India Innovation Fund and Kitven.

← All latest storiesBack to top →